Holiday Notification: Cayman Chemical will be closed Monday, September 6, 2010, in observance of the Labor Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, September 7, 2010. Thank you for your patience.
Research Area · Apoptosis
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 34720 |
15(S)- |
54845-95-3 | ≥98% |
|
41.036397000789 | 15-s-hete | soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated 15HETEs | ||||
| 334720 |
15(S)- |
84807-87-4 | ≥99% deuterated product |
|
44.654696132596 | 15-s-hete-d8 | GC/MS deuterium isotopes 15-HETE-d8 standards 15S-HETE-d8 15(S)HETE-d8 deuterated GC-MS LC/MS LC-MS 15-HETEs 15(S)-HETEs 15S-HETEs 15(S)HETEs hydroxy fatty acids mass spectrometry 15HETE | ||||
| 534721 |
15(S)- |
- |
|
81.124019337016 | 15-s-hete-eia-kit | 15(S)-HETE ELISA Kit | 15(S)-HETEs 15S-HETEs measures kits eias enzyme immunoassays ELISAs 15(S)HETEs 15HETEs assays | ||||
| 10007251 |
15(S)- |
54845-95-3 | ≥98% |
|
2009-02-17 | 19.556098597535 | 15-s-hete-lipid-maps-ms-standard | soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated MS mass spectrometry standards 15HETE | |||
| 10005229 |
2,3- |
- | >98% |
|
2006-09-15 | 17.579861878452 | 2-3-dcpe-hydrochloride | apoptosis Bcl-XL p21 ERK cancers cells cycles proapoptotic in vitro S-phase arrest upregulate activates activation | |||
| 10009856 |
7- |
- | 2008-10-29 | 14.545303867403 | 7-aad-cell-viability-assay-kit | 7-Amino Actinomycin D Cell Viability Kit | kits 7AAD measurement cells fixation blocking cytoxicity effects environmental toxins drug fluorescence fluorescent cell-based assays cell based assay cba | ||||
| 600120 |
7- |
- | 2009-08-05 | 35.546281767956 | 7-aad-cfse-cell-mediated-cytotoxicity-assay-kit | 7-Amino Actinomycin D; 5-(6)-Carboxyfluorescein Diacetate Succinimidyl Ester | 7-amino actinomycin D/5-(6)-carboxyfluorescein diacetates succinimidyls esters assays kits measuring measurement kits 5-(6) 5,6 5-6 7AAD cells cytoxicity cell-based cba cytolysis target effector T lymphocytes NK natural killer autoimmune systems pathological cancers multiple sclerosis granule exocytosis pathways Fas diseases graft host 51chromium 51Cr green fluorescent fluorescence probes red propidium iodide dead effector carboxyfluorescein succinimidyl esters dyes damaged DNA deoxyribonucleic acids quantify quantification single staining | ||||
| 53400 |
(±)9,10- |
263399-34-4 | >98% |
|
31.167090239410 | -9-10-dihome | Leukotoxin diol; (+/-)9(10)-dihydroxy-octadec-12-enoic Acid | epoxides epoxygenase leukotoxin cytochrome P450 (+/-)9(10)-DiHOMes (+/-)9,10-DiHOMes CYP450 | |||
| 10009993 |
(±)9,10- |
- | ≥99% deuterated product |
|
2007-06-01 | 23.367071823204 | -9-10-dihome-d4 | epoxides epoxygenase leukotoxin cytochrome P450 (+/-)9(10)-DiHOMes (+/-)9,10-DiHOMes CYP450 deuterated duteriums | |||
| 52400 |
(±)9(10)- |
- | >98% |
|
20.054792817679 | -9-10-epome | Leukotoxin; 9,10-EODE | epoxides epoxygenasse leukotoxin cytochrome P450 (+/-)9(10)-EpOMEs (+/-)9,10-EpOMEs epoxy fatty acids | |||
| 10009995 |
(±)9(10)- |
- | ≥99% deuterated product |
|
2007-06-01 | 22.597882136279 | -9-10-epome-d4 | Leukotoxin-d4; 9,10-EODE-d4 | epoxides epoxygenasse leukotoxin cytochrome P450 (+/-)9(10)-EpOMEs (+/-)9,10-EpOMEs epoxy fatty acids deuterated deuterium | ||
| 10008051 | Acid Phosphatase Assay Kit | - |
|
2006-09-20 | 6.141528545119 | acid-phosphatase-assay-kit | aps hydrolase eznymes prostate pap tartrate resistant assays | ||||
| 10006908 | Adipogenesis Assay Kit | - |
|
2006-08-18 | 79.845113008538 | adipogenesis-assay-kit | obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines endocrinology cell-based assays cell based assay cba | ||||
| 10009381 | Adipolysis Assay Kit | - |
|
2007-07-30 | 41.588784530386 | adipolysis-assay-kit | obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines lipolysis 3T3L1 kits assays FFA adipocytes endocrinology cell-based assay cell based assay cba | ||||
| 10010129 |
AG- |
199800-49-2 | ≥98% |
|
2008-12-16 | 87.188011049723 | ag-041r | CCKs gastrin receptors antagonist cancers proliferations apoptosis NS-398 NS398 NS 398 | |||
| 10010311 |
AG- |
133550-30-8 | >98% |
|
2007-12-01 | 4.547441988950 | ag-490 | PTK tyrosine kinase inhibitors inhibition inhibits antiproliferatives tyrphostins leukemia Jak-2 Jak2 AG490 | |||
| 360773 | AIF Blocking Peptide | - | 0.177900552486 | aif-blocking-peptide | Apoptosis-Inducing Factor; Programmed Cell Death Protein 8 | human peptides controls factors WB western blots blotting antibodies apoptosis | |||||
| 160773 | AIF Polyclonal Antibody | - | 0E-12 | aif-polyclonal-antibody | Programmed Cell Death Protein 8; Apoptosis-Inducing Factor Polyclonal Antibody | apoptosis antibodies western blots blotting WB antisera antiserum factors cancers immunoblotting | |||||
| 600300 | Annexin V FITC Assay Kit New | - |
|
2010-05-11 | 35.555555555556 | annexin-v-fitc-assay-kit | assays kits measures measurements apoptosis cells death cycles tissues homeostasis dysregulation neurodegenerative diseases ischemic damages autoimmune disorders cancers drugs discovery signaling pathways membranes phospholipids phosphatidylserines phosphatidylethanolamines leaflets bilayers externalizations residues plasma phospholipids binding proteins fluorochrome-labeled fluorochromes fluorescence microscopy flow cytometry FC plate readers TUNEL TdT-mediated dUTP Nick-End Labeling analysis ISEL in situ end labeling DNA laddering detection fragmentation FITC-conjugated fluoresceins | ||||
| 360780 |
Apaf- |
- | 0.483425414364 | apaf-1-blocking-peptide | peptides controls apoptosis cell death caspases CED-4 Apaf2 Apaf3 Apaf-2 Apaf-3 Apafs antibodies Apaf1 CED4 protease-activating factors proteases | ||||||
| 160780 |
Apaf- |
- |
|
1.519576427256 | apaf-1-polyclonal-antibody | Apoptosis Protease-Activating Factor 1 | apoptosis cell death caspases CED-4 Apaf2 Apaf3 Apaf-2 Apaf-3 Apafs antibodies Apaf1 CED4 western blots blotting WB protease-activating factors proteases antisera antiserum cancers immunoblotting | ||||
| 10010750 | Apoptotic Blebs Assay Kit | - |
|
2008-02-29 | 46.763314917126 | apoptotic-blebs-assay-kit | assays fluorescence fluorescent fluorometric apoptosis kits cell-based assay cell based assay cba | ||||
| 160737 | ARC Polyclonal Antibody | - |
|
9.948480662983 | arc-polyclonal-antibody | Apoptosis Repressor with CARD | apoptosis cell death domain DD CARD caspase antibodies western blots blotting WB antisera antiserum cancers immunoblotting IP immunoprecipitation | ||||
| 600140 | Autophagy/Cytotoxicity Dual Staining Kit | - |
|
2009-07-14 | 90.794762430939 | autophagy-cytotoxicity-dual-staining-kit | assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis | ||||
| 10010266 |
BAY- |
19542-67-7 | ≥98% |
|
2008-07-25 | 37.916053670087 | bay-11-7082 | inhibitors inhibits inhibition NFkB NF-.kappa.B NF-kB NF-kappaB TNF.alpha. TNFa TNFalpha I.kappa.B-.alpha. IkB-a IkappaB-alpha inflammation cytokine cell adhesion ICAM-1 ICAM1 VCAM-1 VCAM1 E-selection Eselection Bay 11-7082 BAY-117821 Bay117082 BAY 117821 | |||
| 10011385 | Bim/BOD (IN) Polyclonal Antibody | - | 2008-04-10 | 1.782872928176 | bim-bod-in-polyclonal-antibody | apotosis BH3 Bcl-2 Bcl-XL cancer immunoblotting WB IHC antibodies western blotting antiserum blots immunohistochemistry | |||||
| 13013 |
(−)- |
856925-71-8 | ≥98% |
|
2009-04-16 | 10.958305709024 | -blebbistatin | (S)-Blebbistatin | inhibitors muscles myosin ATPase smooth muscle bleb apoptosis cell migration chemotaxis cytokinesis cells division growth UV light blebs (-)-(S)-Blebbistatin | ||
| 13165 |
(+)- |
- | ≥98% |
|
2009-04-16 | 6.012928176796 | -blebbistatin | (R)-Blebbistatin | inhibitors muscles myosin ATPase smooth muscle bleb apoptosis cell migration chemotaxis cytokinesis cells division growth UV light (+)-(R)-Blebbistatin inhibition inhibited | ||
| 13186 |
(±)- |
674289-55-5 | ≥98% |
|
2009-06-09 | 3.006464088398 | -blebbistatin | inhibitors muscles myosin ATPase smooth bleb apoptosis cells migration chemotaxis cytokinesis division growth UV lights | |||
| 10007958 |
C- |
202850-01-9 | >98% |
|
2006-04-12 | 15.664456721915 | c-12-nbd-ceramide | N-C12-NBD-D-erythro-Sphingosine | ceramides cerimidases fluorescent fluorescence substrates N-acyl fatty acids sphingosine bases isoforms neutral alkalines catalytic pH analogs hydrolyzed hydrolysis P. aeruginosa mouse liver mammalian cells lines kinases sphingomyelin synthases | ||
| 10008097 |
C- |
- | >98% |
|
2006-04-13 | 10.841160220994 | c-12-nbd-dihydro-ceramide | N-C12-NBD-D-erythro-dihydro-Sphingosine | ceramides cerimidases fluorescent fluorescence substrates N-acyl fatty acids sphingosine bases isoforms neutral alkalines catalytic pH analogs hydrolyzed hydrolysis P. aeruginosa mouse liver mammalian cells lines kinases sphingomyelin synthases | ||
| 10005270 | C75 | 191282-48-1 | >98% |
|
2004-09-22 | 29.944714548802 | c75 | inhibits inhibitors inhibition fatty acids synthases FAS cerulenin cytotoxicity apoptosis cancers anorexigenic stable weight loss feeding endocrinology | |||
| 13907 |
Caspase- |
- |
|
2010-07-12 | 300.437306629834 | caspase-1-monoclonal-antibody-clone-14f468 | IL-1β Converting Enzyme | antibodies caspases caspase1 cysteine proteases cell death apoptosis prodomain catalytic subunits receptors ligand growth factor CED-3 CED3 western blots blotting immunoblotting WB immunohistochemistry IHC proteins IL-1β ICE IL1β IL-1b IL1b apoptosis inflammatio | |||
| 13906 |
Caspase- |
- |
|
2010-07-12 | 300.437306629834 | caspase-1-polyclonal-antibody | IL-1β Converting Enzyme | antibodies caspases caspase1 cysteine proteases cell death apoptosis prodomain catalytic subunits receptors ligand growth factor CED-3 CED3 western blots blotting immunoblotting WB immunohistochemistry IHC proteins ICE IL1β IL-1β | |||
| 13908 |
Caspase- |
- |
|
2010-07-21 | 300.437306629834 | caspase-2-monoclonal-antibody-clone-18e809-3 | caspases cysteine antibodies western blots blotting immunoblotting WB cell death apoptosis mRNA caspase-3 serine protease 2 granzyme B lytic granules cytotoxic lymphocytes | ||||
| 10009135 |
Caspase- |
- |
|
2007-08-06 | 47.021436464088 | caspase-3-fluorescence-assay-kit | assays kits caspases fluorescent cells death apoptosis necrosis aspartate-specific cysteinyl fluorescence fluorometric proteases family mitochondrial mitochondria electrons transport oxidative phosphorylation adenosine triphosphate ATP cytochromes C caspase-9 anti-cancers drugs N-Ac-DEVD-N'-MC-R110 HTS high throughput screening N-Ac-Asp-Glu-Val-Asp-CHO cell-based assay cell based assay cba | ||||
| 360745 |
Caspase- |
- | 0.711602209945 | caspase-3-human-blocking-peptide | Yama; ICE3; CPP32; Apopain | control peptides blots blotting western cpp-32 ice-3 apoptosis effectors caspases cell death wb antibodies | |||||
| 160745 |
Caspase- |
- |
|
23.398742031449 | caspase-3-human-polyclonal-antibody | Yama Polyclonal Antibody; ICE3 Polyclonal Antibody; CPP32 Polyclonal Antibody; Apopain Polyclonal Antibody | antibodies blots blotting western cpp-32 ice-3 apoptosis effectors caspases cell death wb antisera antiserum cancers immunoblotting IHC immunohistochemistry | ||||
| 13909 |
Caspase- |
- |
|
2010-08-10 | 300.437306629834 | caspase-3-monoclonal-antibody-clone-31a1067 | Apopain; ICE3; Yama; CPP32 | caspases caspase 3 cysteine proteases cell death apoptosis antibodies western blots blotting immunoblotting WB immunohistochemistry IHC frozen paraffin-embedded paraffin embedded yama CPP32 apopain codes PARP poly(ADP-ribose) polymerase DNA-PK DNAPK DNA PK actin GAS2 pro-caspase procaspase pro CrmA small large subunits | |||
| 10007630 |
Caspase- |
- | >95% by SDS-PAGE | 2006-01-04 | 21.196236187845 | caspase-8-human-recombinant | MCH5; MACH; FLICE | proenzymes procaspases-8 interleukins ILs IL-1b IL-1.beta. ICE family cysteines proteases cells apoptosis aspartate residues self-proteolysis cleavage large small subunits activates downstream caspase-3 caspase-6 caspase-7 cellular substrates death cancer | |||
| 160790 |
Caspase- |
- |
|
45.207771639042 | caspase-9-polyclonal-antibody | MCH6 Polyclonal Antibody; ICE-LAP6 Polyclonal Antibody; Apaf-3 Polyclonal Antibody | apoptosis cell death Apaf-1 apafs caspase-3 caspases antibodies Apaf1 western blots blotting WB an tisera antiserum cancers immunoblotting | ||||
| 72510 | CAY10406 | - | >98% |
|
16.471104972375 | cay10406 | selectively inhibits inhibitors caspase-3 caspase-7 apoptosis apoptotic signal inhibition CAY-10406 | ||||
| 70635 | CAY10416 | 443919-96-8 | >95% |
|
2007-07-24 | 19.453756906077 | cay10416 | COX-2 cyclooxygenases 5-LO lipoxygenases inflammation inhibitors prostates cancers PC3 LNCaP carcinomas apoptosis inhibition inhibits chemotherapy cells lines | |||
| 10005019 | CAY10433 Exclusive | 537034-17-6 | >98% |
|
✓ | 2005-01-05 | 49.714043710572 | cay10433 | BML-210; N-phenyl-N'-(2-Aminophenyl)hexamethylenediamide | HDAC deacetylases histone inhibits inhibitors inhibition cancer cells differentiation gene expression regulation Trichostatin A nuclear extracts deacetylation transcription factors FOXO3 SIRT1 H2O2 hydrogen peroxides BML210 | |
| 10004177 | CAY10443 | 582314-48-5 | >98% |
|
2004-06-17 | 1.373950276243 | cay10443 | (S)-Indan-1-yl 3,4-dichlorobenzylcarbamate | DNA binding anti-oncogenic apoptosis cancer p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic | ||
| 10008012 | CAY10500 Exclusive | - | >98% |
|
✓ | 2006-08-07 | 55.490349907919 | cay10500 | TNF-.alpha. TNF.alpha. signal transduction inflammation small-molecule inhibitor cytokine apoptosis NF-kB AP-1 inhibitor antagonist | ||
| 10008872 | CAY10503 | - | >98% |
|
2007-08-02 | 49.169944751381 | cay10503 | apoptosis antiproliferation cancers differentiation HL60 cells cycles proliferative positive markers CD14 CD11b CD11c monocytic granulocytic | |||
| 10010043 | CAY10561 Exclusive | 933786-58-4 | >98% |
|
✓ | 2008-03-06 | 4.249723756906 | cay10561 | Pyrazolylpyrrole ERK Inhibitor | MEK Ras Raf ERK2 proliferation cell cycles cancers apoptosis inhibition inhibit inhibitors | |
| 10011256 | CAY10577 | 300675-28-9 | ≥95% |
|
2008-09-02 | 0.397790055249 | cay10577 | inhibitors inhibits inhibition CK2 kinase cell signaling apoptosis cancers | |||
| 10011264 | CAY10578 | 19231-60-8 | ≥95% |
|
2008-08-26 | 0.397790055249 | cay10578 | inhibitors inhibits inhibition kinase cell signaling CK2 apoptosis cancers isoindolineacetic acids | |||
| 13291 | CAY10616 Exclusive | 586410-08-4 | ≥98% |
|
✓ | 2009-12-01 | 15.154834303036 | cay10616 | resveratrols apoptosis cancers leukemia HL-60 cells HL60 HL 60 multidrug-resistance multidrug resistance multi-drug multi-drug-resistant daunorubicin etoposides citarabines phenols cytarabines HL60R | ||
| 13836 | CAY10625 Exclusive New | 137346-42-0 | ≥95% |
|
✓ | 2010-06-23 | 0E-12 | cay10625 | apoptosis Smac Diablo Survivin cancers antagonists INCENP doxorubicin caspase-3 caspase-7 Aurora B kinases Borealin caspases cell-permeable antagonists smac/diable smac-diablo | ||
| 10004985 |
Caylin- |
- | >98% |
|
2005-09-09 | 24.657108655616 | caylin-1 | caylin1 mdm-2 cancer Nutlin-3 analogs p53 inhibits inhibitors inhibition interaction Mdm2 negative regulators activity chlorine substituents phenyl rings growth HCT-116 cells promotes | |||
| 10005002 |
Caylin- |
- | >98% |
|
2004-07-12 | 21.455698500394 | caylin-2 | apoptosis cancer p53 inhibits inhibitors induces apoptotic re-activation reactivation antioncogenic tumors xenografts HCT-116 caylin2 | |||
| 13172 | CBHA | 174664-65-4 | ≥98% |
|
2009-06-24 | 39.813042620363 | cbha | Histone Deacetylase Inhibitor II; m-Carboxycinnamic Acid bis-Hydroxamide | histones deacetylase HDACs HDAC1 HDAC3 apoptosis cancers neuroblastoma tumors retinoic acids inhibitors inhibits inhibition | ||
| 10339 |
CD25 Monoclonal PE Antibody (Clone 143- |
- |
|
✓ | 2010-06-09 | 1.132596685083 | cd25-monoclonal-pe-antibody-clone-143-13 | p55; IL-2Rα; Tac; Interleukin-2 receptor α subunit | antibodies antiserum IF FC flow cytometry immunofluorescence interleukins 2 IL-2 IL2 cytokines immunochemical | ||
| 10004837 | CD27 Monoclonal Antibody (Clone 203.6) | - | 2005-09-16 | 4.521180311401 | cd27-monoclonal-antibody-clone-203-6 | antibodies antisera antiserum IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type II transmembranes glycoproteins leukocytes proteins tetraspanin superfamily antigens alternative splicing isoforms human B cells pro-B plasma T macrophages neutrophils platelets erythrocytes Anti-CD37 immunophenotyping neoplasia hairy chronic lymphocytic non-Hodgkin's lymphoma expression lymphocytes T cells NK activated memory monocytes granulocytes dendritic B anti-CD45 mAB lymphoid malignancies malignant cancer FC | |||||
| 10004835 |
CD34 Monoclonal Antibody (Clone ICO- |
- | 2005-09-16 | 4.827484062898 | cd34-monoclonal-antibody-clone-ico-115 | antibodies antisera antiserum ICC immunocytochemistry FACS flow cytometry type I transmembranes glycoproteins proteins antigens isoforms stem cells embryonic fibroblasts neurons Anti-CD34 differential staining acute leukemias cancers malignant malignancies ICO115 FC | |||||
| 10004718 |
CD37 Monoclonal Antibody (Clone IPO- |
- | 2005-09-16 | 4.521180311401 | cd37-monoclonal-antibody-clone-ipo-24 | antibodies antisera antiserum IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type III transmembranes glycoproteins leukocytes proteins tetraspanin superfamily antigens alternative splicing isoforms human B cells pro-B plasma T macrophages neutrophils platelets erythrocytes Anti-CD37 immunophenotyping neoplasia hairy chronic lymphocytic non-Hodgkin's lymphoma expression lymphocytes T cells NK activated memory monocytes granulocytes dendritic B anti-CD45 mAB lymphoid malignancies malignant cancer FC | |||||
| 10009852 |
CD4/CD8 Monoclonal FITC/PE Antibody (Clone RIV7/OKT- |
- | 2008-09-03 | 3.397790055249 | cd4-cd8-monoclonal-fitc-pe-antibody-clone-riv7-okt-8 | antibodies antisera antiserum FC flow cytometry human whole blood cells lysis white CD4-CD8 CD4+CD8 | |||||
| 10004604 |
CD95 Monoclonal Antibody (Clone IPO- |
- | 2004-06-17 | 0.625675874769 | cd95-monoclonal-antibody-clone-ipo-4 | APO-1; Fas; Tumor Necrosis Factor Receptor Superfamily, Member 6; TNFRSF6; Apoptosis Antigen; APT | glycoproteins blots blotting antibodies antisera antiserum DNA binding anti-oncogenic apoptosis cancers p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic immunocytochemistry immunohistochemistry IHC icc FC flow cytometry | ||||
| 10009349 | Cell Cycle Phase Determination Kit | - | 2007-04-20 | 40.741099984653 | cell-cycle-phase-determination-kit | assays kits measures measurements microscopy flow cytometry plate readers regulators cells transcription factors DNA proteins division proliferation induction inhibition fixation permeabilization staining sub-G1 G0 G2 S propidium iodide apoptosis cancer cell-based assay cell based assay cba | |||||
| 10005647 | Cerulenin | 17397-89-6 | >98% |
|
2004-09-01 | 27.366878453038 | cerulenin | tumor cells fatty acid synthases FAS inhibits inhibitors inhibition cytotoxicity apoptosis cancer diet obesity | |||
| 160755 | DcR2 Polyclonal Antibody | - | 1.483977900552 | dcr2-polyclonal-antibody | TRUNDD Polyclonal Antibody; TRAIL-R4 Polyclonal Antibody | apoptosis cell death TNF DR4 DR5 DcR1 TRID TRAIL antibodies western blots blotting WB antisera antiserum immunoblotting | |||||
| 10005432 | DDA | 25152-84-5 | >98% |
|
2004-07-22 | 21.122555248619 | dda | trans-2,4-Decadien-1-al; Decadienealdehyde | lipoxygenases diatoms alkyls linoleic acids dihomo-gamma-linolenic dihomo-g-linolenic arachidonic dihomo-.gamma.-linolenic carcinoma Caco2 apoptosis | ||
| 10010706 |
(−)- |
522-17-8 | >98% |
|
2008-09-18 | 1.759668508287 | -deguelin | (-)-cis-Deguelin | rotenoids flavonids cancers antiproliferative chemoprevention parkinsons diseases Akt PKB PI3K COX-2 COX2 apoptosis PI3-K | ||
| 10165 |
D- |
143492-38-0 | >98% |
|
2004-02-23 | 17.747691835482 | d-erythro-mapp | (1S,2R-D-erythro-2-N-myristoylamino)-1-phenyl-1-propanol | ceramides inhibitors sphingolipids HL60 HL-60 cancer cells G0/G1 G0-G1 inhibits ceramidase | ||
| 10009081 | Didox Exclusive | 69839-83-4 | >98% |
|
✓ | 2007-01-16 | 13.587292817679 | didox | antioxidants hydroxamic acids apoptosis cancers cells polyhydroxylated aromatic ocidative injury brains HIV dementia bcl-2 | ||
| 62237 |
Diphenyl- |
110231-30-6 | >98% |
|
2006-07-25 | 62.428694751381 | diphenyl-1-pyrenylphosphine | DPPP | hydroperoxides oxidative stress injury fluorescence fluorescent lipids cholesterols LDL oxidation DPPPO DPPP=O atherosclerosis | ||
| 660990 | DNA Laddering Kit | - | 0.117845303867 | dna-laddering-kit | kits assays apoptosis | ||||||
| 10006305 |
D- |
35922-06-6 | >98% |
|
✓ | 2005-02-23 | 8.559337016575 | d-nmappd | CAY10466; (1R,2R)-B13 | ceramides inhibitors cancers cells inhibits inhibition ceramidase apoptosis colorectal keratinocytes melanoma lines viability inducers induces | |
| 700210 | DPP (IV) Inhibitor Screening Assay Kit | - |
|
2009-05-27 | 115.718314917126 | dpp-iv-inhibitor-screening-assay-kit | Dipeptidyl exopeptidases IV DPPIV DPP4 enzymes CD26 cluster of differentiation T-cells activation antigens adenosine deaminase complexing 2 membrane-bound glycoproteins immune regulation signal transduction apoptosis kidneys small intestines placentas humans serums seminal fluids proteolytic derivatives serines X-prolines X-alanines dipeptides N-terminus N-terminal polypeptides growth factors chemokines neuropeptides vasoactive inhibitors inhibits inhibition oral antidiabetic agents glucose homeostasis glucoregulatory hormones glucose-dependent insulinotropics GIP glucagon-like peptide-1 GLP-1 gastric therapeutics Type 2 tumors cancers markers neoplasms assays kits measures measurements fluorescences fluorescent fluorogenics substrates Gly-Pro-Aminomethylcoumarin AMC | ||||
| 10010302 | DRB | 53-85-0 | >98% |
|
2008-01-21 | 4.171823204420 | drb | Benzimidazole; NSC 401575 | cancers HIV P53 apoptosis CDK7 CDK9 CTD CKI CKII adenosine inhibitors inhibits inhibition transcription RNA polymerase cell cycles adenocarcinoma transactivator tat | ||
| 10011192 | Elesclomol Exclusive | 488832-69-5 | ≥98% |
|
✓ | 2009-04-23 | 6.298637200736 | elesclomol | STA 4783; NSC 174939 | cancer apoptosis melanoma ROS oxidative stress Hsp70 metallothionein STA-4783 874477-56-2 | |
| 10022 | F16 | 36098-33-6 | >98% |
|
6.659171270718 | f16 | apoptosis induces apoptotic mitochodrial membranes tumors inhibitors fluorescent F-16 cancer inhibits fluorescence lipophilic binding HER-1/EGFR-expressing inhibition cells breast | ||||
| 13287 |
FK- |
658084-64-1 | ≥98% |
|
2009-07-21 | 55.106187845304 | fk-866 | K 22.175 | nicotinamides phosphoribosyltransferase NAMPT NamPRT PBEF visfatin mononucleotides adenine dinucleotide NAD+ inhibitors inhibitis inhibition cancers apoptosis SIRT1 autophagy FK866 FK 866 K22.175 K 22175 K22175 NamPRT PBEF visfatin carcinoma cells autophagy | ||
| 13227 | Fumonisin B2 | 116355-84-1 | ≥98% |
|
2009-11-11 | 23.272510904332 | fumonisin-b2 | mycotoxins fungus corn grains sphingosines inhibitors N-acyltransferase apoptosis sphingolipids hepatotoxicity nephrotoxicity fungi | |||
| 13355 | Geldanamycin New | 30562-34-6 | 98% |
|
2010-07-29 | 3.207182320442 | geldanamycin | NSC 122750 | NSC 212518 antibiotics heat shock proteins 90 Hsp90 GRP94 gp96 genes expression cells proliferation apoptosis angiogenesis c-jun adenocarcinoma cancers AP-1 steroids receptors | ||
| 10010622 | Genipin | 6902-77-8 | >98% |
|
2008-05-09 | 150.674033149171 | genipin | (+)-Genipin | obesity diabeties glucose insulin mitochondria UCP2 pancreatic .beta. cells anti-inflammatory antiinflammatory angiogenesis inhibitors inhibits inhibition uncoupling proteins 2 un-coupling angiogenesis apotosis diabetes inflammation metabolism obesity | ||
| 10136 |
GPR17 (C- |
- |
|
2010-01-19 | 50.866858118477 | gpr17-c-term-polyclonal-antibody | G Protein-Coupled Receptor 17 | proteins receptors antibodies western blots WB ICC signals signaling nucleotides CysLTs amino acids blotting immunoblotting FC flow cytometry immunocytochemistry cysteinyl leukotrienes | |||
| 10006798 | GW 0742 | 317318-84-6 | >98% |
|
2007-07-25 | 48.434872928176 | gw-0742 | PPAR PPAR.beta. PPAR.delta. peroxisome proliferator activated receptor neurotoxicity agonists neuroprotection toxicity apoptosis lipids metabolism atherosclerosis endocrinology GW0742 GW-0742 | |||
| 13127 | GW 4869 | 6823-69-4 | ≥90% |
|
2009-06-10 | 56.436985880908 | gw-4869 | inhibitors sphingomyelin sphingomyelinase neutral acidic TNF-α ceramides cells death GW4869 gw-4869 | |||
| 10008313 | GW 610 | 872726-44-8 | >98% |
|
2006-05-10 | 28.267204419889 | gw-610 | NSC 721648 | antitumors benzothiazoles inhibits inhibitors inhibition cancers antiproliferative isoflavones quercetin genistein cells MCF-7 MDA 468 NCI 60 | ||
| 10007713 |
HMB- |
862891-04-1 | >98% |
|
2006-07-20 | 52.590810313076 | hmb-val-ser-leu-ve | 26S protease 20S ubiquitin-proteasomes pathway proteolysis proteins regulated degradation tripeptides C-terminal vinyl esters inhibits inhibition inhibitors trypsin tryptic chytotryptic cells permeable in vitro | |||
| 13782 | I2PP2A/SET Polyclonal Antibody New | - |
|
2010-05-10 | 300.437306629834 | i2pp2a-set-polyclonal-antibody | Phosphatase 2A Inhibitor; Template-Activating Factor I; Inhibitor of granzyme A-activated DNase; PHAPII | antibodies WB western blots blotting immunoblotting histones INHAT1 INHAT 1 coactivators transcription cells TAF1α TAF 1α TAF1β TAF 1β SETs INHAT-1 protein SET SET/I2PP2A TAF-1 TAF 1 TAF1 TAF-1beta TAF-1.beta. IGAAD | |||
| 10008207 | IGFBP5 Polyclonal Antibody | - |
|
2007-07-19 | 31.501896869244 | igfbp5-polyclonal-antibody | IGF-Binding Protein 5; IBP-5; Insulin-like Growth Factor Binding Protein 5 | IGF-1 cell growth differentiation apoptosis receptors kidney heart placenta skeletal cancers amino acids neuroblastoma mammary glands antibodies wb western blots immunocytochemistry IGF1 IGFBP-5 endocrinology blotting immunoblotting | |||
| 13323 |
IM- |
861891-50-1 | ≥95% |
|
2009-10-14 | 0.142857142857 | im-54 | inhibitors necrosis necrotic cells death peroxide HL-60 leukemia apoptosis PKC S6K1 protein kinases C S6 1 indolymaleimide | |||
| 10009172 |
JC- |
- |
|
2007-04-12 | 177.854206787687 | jc-1-mitochondrial-membrane-potential-assay-kit | apoptosis cells mitochondria caspases cytochrome C electrons transport transmembranes Dym DELTApsim .DELTA..psi.m fluorscence fluorescent cationic dyes rhodamine-123 Rh123 DiOC6 cytofluorimetric lipophilic tetrachloro-1,1',3,3'-tetraethylbenzimidazoylcarbocyanine iodide green red J-aggregates monomeric assays kits measures measurements microscopy flow cytometry plate readers fluorometric cancer JC1 cell-based assays cell based assay cba JC 1 | ||||
| 70980 | Lactacystin | 133343-34-7 | >98% |
|
196.427969613260 | lactacystin | selective inhibitors neuroblastoma pleiotropic neurites 20S proteasomes inhibits streptomyces cells Neuro2A apoptosis inhibition death | ||||
| 10008882 | LDH Cytotoxicity Assay Kit | - |
|
2006-12-15 | 125.354493554327 | ldh-cytotoxicity-assay-kit | Lactate Dehydrogenase Cytotoxicity Assay Kit | cells death apoptosis necrosis measuring measurement cystolic enzymes cells membranes integrity cancer cell-based assays cell based assay cba | |||
| 13776 |
Mammalian STE- |
- |
|
2010-04-28 | 300.437306629834 | mammalian-ste-20-like-kinase-1-polyclonal-antibody | STK4; KRS2; MST-1 | antibodies western blots blotting immunoblotting WB MST1 STE 20 STE20 KRS-2 KRS 2 STK-2 STK terminal terminus NES nuclear export signals proteins apoptosis epigenetics | |||
| 13320 |
MCI- |
89-25-8 | ≥98% |
|
2010-07-15 | 0E-12 | mci-186 | NSC 2629; Edaravone | free radical scavengers inhibitors inhibits inhibition ischemia-reperfusion injury transplants infections traumatic brain injury injuries strokes reactive oxygen species apoptosis Norantipyrine Norphenazone Radicut 206195-95-1 115566-83-1 72134-66-8 62495-97-0 52224-17-6 12235-58-4 methylphenylpyrazolone NSC 26139 NSC 12 Edarabone | ||
| 600160 | Methionine Sulfoxide Immunoblotting Kit | - |
|
2009-12-17 | 143.321805433729 | methionine-sulfoxide-immunoblotting-kit | MetO Immunoblotting Kit | proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 | |||
| 10007188 |
Microcystin- |
101043-37-2 | >95% |
|
2005-07-20 | 96.460883977900 | microcystin-lr | Cyanoginosin-LR | proteins phosphatases inhibitors microcystins toxins hepatotoxic cyclics heptapeptides cyanobacteria poisonings humans livestock fresh water blue-green algae endemic PP-2A inhibits enzymes PP-1 serine/threonine nodularins okadaic acids | ||
| 13600 | MK 0457 New | 639089-54-6 | ≥98% |
|
2010-08-16 | 0E-12 | mk-0457 | Tozasertib; VX 680 | mitosis aurora kinase inhibitors inhibits inhibition MK0457 MK-0457 MK-457 MK457 cells cycles cancers apoptosis tumor A B C | ||
| 600330 |
Multi- |
- |
|
2010-08-18 | 5.555555555556 | multi-parameter-apoptosis-assay-kit | assays kits measures measurements apoptosis cells death cycles tissues homeostasis dysregulation neurodegenerative diseases ischemic damages autoimmune disorders cancers drugs discovery signaling pathways membranes phospholipids phosphatidylserines phosphatidylethanolamines leaflets bilayers externalizations residues plasma phospholipids binding proteins fluorochrome-labeled fluorochromes annexin V fluorescence microscopy flow cytometry FC plate readers TUNEL TdT-mediated dUTP Nick-End Labeling analysis ISEL in situ end labeling DNA deoxyribonucleic acids mitochondrial transmembranes tetramethylrhodamines ethyls esters TMRE lipophilics probes laddering detection fragmentation FITC-conjugated fluoresceins | ||||
| 10008581 | Myristoleic Acid methyl ester | 56219-06-8 | >98% |
|
2007-04-17 | 0.791325966851 | myristoleic-acid-methyl-ester | cytotoxic Serenoa S. repens apoptosis necrosis prostate cancers cheese whey fatty acids Candida C. albicans MIC minimal inhibitory concentration in vivo esters hydrophobic | |||
| 10017 |
N- |
184179-08-6 | >98% |
|
2004-04-29 | 4.367889502762 | n-ac-asp-glu-val-asp-cho | Ac-DEVD-CHO | Valinamide caspases caspase 3 inhibitors Yama ICE3 CPP32 Apopain inhibition inhibits selective apoptosis | ||
| 10016 |
N- |
143313-51-3 | >98% |
|
2004-04-14 | 8.314088397790 | n-ac-tyr-val-ala-asp-cho | Ac-YVAD-CHO | inhibitor inhibits apoptosis interleukins inhibition selective irreversible interleukin-1.beta.converting enzyme ICE Caspase-1-IL-1.beta. Il1beta neuroprotective cerebral ischemia alaninamides | ||
| 10014 |
N- |
178603-78-6 | >98% |
|
2004-04-13 | 10.728784530386 | n-ac-tyr-val-ala-asp-cmk | Ac-YVAD-CMK | inhibitors inhibits interleukins neuroprotective cerebral ischemia inhibition selective irreversible interleukin-1.beta.converting enzyme ICE Caspase-1-IL-1.beth. IL1beta neuroprotective cerebral ischemia alaninamides neurochemistry chloromethyl ketones | ||
| 13754 |
NF- |
- |
|
2010-04-27 | 34.441053406998 | nf-b-p50-polyclonal-antibody | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors DNA p65 N-terminal binding western blots blotting immunoblotting WB antibodies | ||||
| 13756 |
NF- |
- |
|
2010-02-11 | 111.440352698253 | nf-b-p65-monoclonal-antibody-biotin-clone-112a1021 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB biotins biotinylated biontinylation 112A1021 clones | ||||
| 13752 |
NF- |
- |
|
2010-02-11 | 111.440352698253 | nf-b-p65-monoclonal-antibody-clone-112a1021 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting flow cytometry FC WB immunohistochemistry IHC | ||||
| 13751 |
NF- |
- |
|
2010-02-11 | 111.440352698253 | nf-b-p65-nls-polyclonal-antibody | Nuclear Factor-κB (p65) Nuclear Localization Signal | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies | |||
| 13757 |
NF- |
- |
|
2010-02-11 | 108.489855460684 | nf-b-p65-polyclonal-antibody-aa-2-17 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 2 7 | ||||
| 13753 |
NF- |
- |
|
2010-02-11 | 111.440352698253 | nf-b-p65-polyclonal-antibody-aa-538-546 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 538 546 | ||||
| 10011255 | NSC 210902 | 51726-83-1 | ≥95% |
|
2008-09-15 | 1.672375690607 | nsc-210902 | Inhibitor inhibits inhibition CK2 kinase cell signaling apoptosis cancers NSC210902 | |||
| 18585 |
(−)- |
- | ≥98% |
|
✓ | 2008-08-06 | 143.446160220994 | -nutlin-3 | Nutlin 3a | P53 cellular stress proliferation cells cycle apoptosis tumor suppressor MDM2 agents Nutlin-3 enantiomer a | |
| 10009816 |
(+)- |
- | ≥98% |
|
✓ | 2008-08-11 | 99.996270718231 | -nutlin-3 | Nutlin 3b | p53 cellular stress proliferation cells cycle apoptosis tumer suppressor MDM2 inactive inhibitors inhibits inhibition Nutlin-3 enantiomer b | |
| 10004372 |
(±)- |
548472-68-0 | >98% |
|
2004-04-06 | 108.302491210446 | -nutlin-3 | apoptosis cancers p53 inhibits inhibitors induces apoptotic re-activation reactivation antioncogenic tumors xenografts license:hoffmanlaroche Nutlin3 nutlins | |||
| 10011301 | p38 MAPK Monoclonal Antibody (Clone 9F12) | - |
|
2008-05-22 | 2.615138121547 | p38-mapk-monoclonal-antibody-clone-9f12 | p38 Mitogen-activated Protein Kinase; p38 MAPKα | serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC | |||
| 10005291 | p53 Product Pack | - | 2004-09-08 | 25.525317679558 | p53-product-pack | DNA binding anti-oncogenic apoptosis cancer p53 re-activators reactivators induces apoptotic re-activation reactivation antioncogenic packs | |||||
| 10009317 |
PAC- |
315183-21-2 | >98% |
|
2007-07-12 | 8.565745856354 | pac-1 | Procaspase-activating Compound 1 | in vitro procaspase-3 apoptosis cancers cells death drugs treatment acivators procaspases PAC1 | ||
| 10461 | Paclitaxel New | 33069-62-4 | ≥98% |
|
2010-08-23 | 0E-12 | paclitaxel | Taxol®; NSC 125973 | Microtubules cancers cervical HeLa lung A549 breast MCF-7 colon HT-29 ovarian OVG-1 pancreatic PC-Sh carcinomas chemotherapy mitotic arrest apoptosis JNK BCL-2 p53 Pacific yew tree c-Jun cyclin-dependent kinases multipolar spindle formation Abraxane Capxol Mitotax Onxal QW 8184 Yewtaxan Tocosol Taxus Liberte Genexol-PM Genetaxyl EndoTAG 1 Ebetaxwl DHP 107 ABI 007 | ||
| 10010518 | PD 146176 | 4079-26-9 | ≥98% |
|
2009-02-25 | 78.610386740332 | pd-146176 | NSC 168807 | atherosclerosis 15-LOs 15-lipoxygenases oxidant injury injuries apoptosis amyloid β proteins inhibitors inhibits inhibitions Alzheimers disease oxidative stress pd146176 | ||
| 10012431 | PD 184161 Exclusive | 212631-67-9 | ≥98% |
|
✓ | 2009-06-09 | 18.628839779005 | pd-184161 | MEK inhibitors MAP kinase ERK signaling cancer MEK 1/2 inhibition inhibited ERK 1/2 potent selective pd184161 | ||
| 10007191 |
PH Domain Leucine- |
- |
|
2006-01-04 | 3.757658839778 | ph-domain-leucine-rich-repeat-protein-phosphatase-polyclonal-antibody | Suprachiasmatic Nucleus Circadian Oscillatory Protein; SCOP; PLEKHE1 Protein; PHLPP; KIAA0606 Protein | proteins diseases antibodies antisera antiserum western blots blotting immunocytochemistry ICC immunohistochemistry IHC cancers WB immunoblotting | |||
| 13326 |
Pifithrin- |
63208-82-2 | ≥95% |
|
2009-07-16 | 22.042012628255 | pifithrin | p53 apoptosis DNA damage cyclin D1 C8 cells HUVECs endothelial cells dependent independent inactivator | |||
| 13527 | Pseudolaric Acid B | 82508-31-4 | ≥98% |
|
2009-12-04 | 3.927272727273 | pseudolaric-acid-b | PAB | Pseudolarix kaempferi traditional Chinese fungal fungus infections cancers apoptosis angiogenesis tumors inhibits inhibitors inhibition P. therapy apoptosis cells | ||
| 10005059 | PTEN Polyclonal Antibody | - |
|
2005-05-04 | 12.888614534636 | pten-polyclonal-antibody | TEP1; Phosphoinositide 3-phosphatase; MMAC1; Phosphatase and Tensin Homology on Chromosome 10 | proteins antibodies antisera antiserum wb western blots blotting IHC immunohistochemistry dephosphorylates lipids AKT phosphatidylinositols triphosphates PIP3 tissues acids regulates cells division migrations apoptosis mutations cancers melanomas prostates carcinomas A431 HEK293 signals transductions cancers endocrinology immunoblotting | |||
| 10009594 | Pyocyanin | 85-66-5 | >98% |
|
2007-07-12 | 11.113812154696 | pyocyanin | Pyocyanine; Sanazin; Sanasin | Pseudonomas aeruginosa phenazine metabolite neutrophil apoptosis Cystic fibrosis | ||
| 301785 | RICK Blocking Peptide | - | 3.125082872928 | rick-blocking-peptide | apoptosis kinases CARD domains RIP-like interacting CLARP Fas western blots blotting WB controls peptides | ||||||
| 160785 | RICK Polyclonal Antibody | - |
|
6.485856353591 | rick-polyclonal-antibody | Ripk2; CCk; Rip2; CARDIAK | apoptosis antibodies kinase CARD domains RIP Fas western blots blotting WB antisera antiserum RIP-2 cancers immunoblotting | ||||
| 10006426 | RITA | 213261-59-7 | >98% |
|
2006-01-11 | 32.044585635358 | rita | NSC 652287; 2,5-bis(5-hydroxymethyl-2-thienyl) Furan | HDM-2 human double minute-2 MDM-2 mouse murine negative regulator p53 proteasomal degradation tumors cancers apoptosis cells reactivation molecules inhibitors wild-type DNA-protein human renal SCID mice HCT116 A-498 xenografts nude HDM2 HDM-2 MDM2 | ||
| 13697 |
(R)- |
- | ≥98% |
|
✓ | 2010-06-22 | 0E-12 | -r-mg132 | ubiquitin proteasomes inhibitors proteolytic degradation inflammation cells cycle regulation cancers NF-κB apoptosis inhibition inhibited | ||
| 13628 | Salidroside New | 10338-51-9 | ≥97% |
|
2010-05-28 | 0E-12 | salidroside | Rhodioloside | glycosides plants Rhodiola Chinese medicine memory infections inflammation cancers diabetes fatigue apoptosis | ||
| 10010401 | SIRT1 Direct Fluorescent Screening Assay Kit | - |
|
2008-02-26 | 34.232278193044 | sirt1-direct-fluorescent-screening-assay-kit | SIRT 1 assays kits measures sirtuins trichostatins A-intensive lysyl-deacetylases class III HDACs human homologs yeast SIR2 silent information regulators 2 tumors cancers suppressors inhibits inhitors inhibition apoptosis screening fluorescence activators fluorescent fluorometric | ||||
| 10010991 |
SIRT1 FRET- |
- |
|
2008-02-19 | 11.583523634131 | sirt1-fret-based-screening-assay-kit | SIRT 1 assays kits measures sirtuins trichostatins A-intensive lysyl-deacetylases class III HDACs human homologs yeast SIR2 silent information regulators 2 tumors cancers suppressors inhibits inhitors inhibition apoptosis screening fluorescence activators fluorescent fluorometric | ||||
| 10011190 | SIRT1 (human recombinant) | - | ≥60% | 2008-09-24 | 12.796063535911 | sirt1-human-recombinant | Silent Information Regulator 2; Sirtuin 1; Sir 2 | SIRT 1 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged | |||
| 10012628 |
(S)- |
133407-82-6 | ≥98% |
|
2009-02-18 | 237.284033149171 | -s-mg132 | 2-Leu-Leu-Leu-CHO | ubiquitin proteasome inhibitors inhibits inhibition proteolytic degradation inflammation cell cycle regulation cancers NF-kB NFkB apoptosis NF-κB mg 132 mg-132 2-LLL-CHO | ||
| 10010466 | SP 600125 | 129-56-6 | ≥98% |
|
2009-01-07 | 5.877348066298 | sp-600125 | 1PMV; Pyrazolanthrone; NSC 75890 | c-Jun cJun JNKs inhibitors inhibits inhibition reversible cell-permeable cells COX-2 COX2 MAP kinase MAPK genes expressions apoptosis autophagy differentiation IL-10 IL10 TNF-α TNFα IFN-γ IFNγ T-cells Tcells HeLa sp600125 | ||
| 700330 | Sphingomyelinase Inhibitor Screening Assay Kit | - |
|
2010-02-09 | 90.860927587085 | sphingomyelinase-inhibitor-screening-assay-kit | assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular cholesterols trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols | ||||
| 62570 |
Sphingosine- |
26993-30-6 | >98% |
|
124.576887661141 | sphingosine-1-phosphate | S1P; sphingosine-1-phosphoric acid | sphingosines phosphates ceramides apoptosis Sphingosine-1-phosphoric acids cells death kinases sphingomyelin growth calcium | |||
| 10012201 | Sphingosine Kinase 1 Polyclonal FITC Antibody Exclusive | - | ✓ | 2008-06-06 | 21.789152854512 | sphingosine-kinase-1-polyclonal-fitc-antibody | SPHK 1 | SPHK-1 metabolism sphingolipids phosphorylation sphingosine-1-phosphate cell proliferation death immunofluorescence IF flow cytometry FC western blots WB SPHKs blotting immunoblotting | |||
| 10008196 | Stearic Acid ethyl ester | 111-61-5 | >98% |
|
2006-05-30 | 1.832800679983 | stearic-acid-ethyl-ester | Ethyl Stearate; Ethyl Octadecanoate; NSC 8919 | esters saturated acids animal vegetable fats lipid soluble ethanol metabolites cells cycle apoptosis HepG2 excessive alcohol hair | ||
| 13577 | SU 11652 | 326914-10-7 | ≥95% |
|
2010-02-02 | 66.017581338245 | su-11652 | growth factors receptors tyrosine kinases RTK inhibitors inhibits platelet-derived PDGF PDGF-β vascular endothelial VEGF VEGFR-2 fibroblast FGF FGFR1 epidermal EGFs EGFRs cells cycling apoptosis Kit c-Kit angiogenesis estrogen SU11652 mutants SU-11652 autophosphorylation | |||
| 70302 | tetramethyl Nordihydroguaiaretic Acid Exclusive | 24150-24-1 | ≥98% |
|
✓ | 2008-09-24 | 9.740276243094 | tetramethyl-nordihydroguaiaretic-acid | tetramethyl NDGA; TMNDGA; Tetrameprocol; M4N; EM-1421 | tumors inhibitor inhibits inhibition cancers NDGAs survivin apoptosis Cdc2 HIV growing growth glioma brains antitumor organic melonomas | |
| 10009813 |
thio- |
- | >98% |
|
2007-08-13 | 13.420165745856 | thio-miltefosine | analogs inhibitors inhibit inhibition CTP phosphocholine cytidylyl transerases antimetastatic antiproliferatives ceramides apoptosis antiprotazoal thiomiltefosine sulfurs thios | |||
| 10038 | TMS | 24144-92-1 | >98% |
|
32.928806629834 | tms | 2,3',4,5'-Tetramethoxystilbene | cytochromes inhibitors tetramethoxystilbene antimutagenesis CYP450-1B1 inhibits selective selectivity apoptosis cell growth | |||
| 13340 | TPEN New | 16858-02-9 | ≥95% |
|
2010-08-03 | 0E-12 | tpen | TPEDA | zinc apoptosis hypoxic pulmonary vasoconstriction chelator cells proliferation differentiation caspases transition metal chelator cancers | ||
| 160750 | TRAIL Polyclonal Antibody | - | 1.483977900552 | trail-polyclonal-antibody | Apo-2L Polyclonal Antibody | apoptosis cell death TNF DR4 DR5 NF-.kappa.B NF-kappab NF-kappab antisera antiserum antibodies WB western blots blotting cancers immunoblotting | |||||
| 13791 | TRF2 Polyclonal Antibody New | - |
|
2010-06-24 | 300.437306629834 | trf2-polyclonal-antibody | TTAGGG Repeat Binding Factor 2; TRBF2; Telomeric Repeat Binding Factor 2; TERF2 | antibodies proteins TRF-2 TRF 2 factors repeat DNA binding cells apoptosis western blots blotting immunoblotting telomere WB ICC IP ChIP IF immunoprecipitation immunofluorescence immunocytochemistry cancers apoptosis | |||
| 10009083 | Trimidox | 95933-74-7 | >98% |
|
2008-02-13 | 0.220994475138 | trimidox | VF 233 | apoptosis ribonucleotide reductases cells cycles cancers dNTP HIV caspase DNA synthesis chemotherapy dGTP HL-60 | ||
| 10011124 | Trimidox (hydrochloride) Exclusive | - | >98% |
|
✓ | 2008-06-10 | 0.220994475138 | trimidox-hydrochloride | CF 233 (hydrochloride) | apoptosis ribonucleotides reductases cells cycles cancers dNTP HIV caspases DNA synthesis chemotherapy dGTP HL-60 HCls | |
| 10005190 | U19 Polyclonal Antibody | - |
|
2004-08-12 | 1.972132596685 | u19-polyclonal-antibody | ELL-Associated Factor 2; EAF2 | WB western blots blotting IHC immunohistochemistry immunoblots formalin-fixed paraffin-embedded sections apoptosis inhibits inhibitors inhibition prostate tumors testosterone suppressive supression leukemogenesis cancers endocrinology immunoblotting | |||
| 10010591 | Wortmannin | 19545-26-7 | ≥98% |
|
2008-11-21 | 36.766139502762 | wortmannin | KY 12420 | phosphoinositide 3-kinase PI3K cells growth differentiations cancers motility inhibitors inhibits inhibition irreversible polo-like kinases PLK1 PLK3 mTOR DNA-PK DNAPK PL4K MLCK p38 MAPK | ||
| 10008883 |
WST- |
- |
|
2006-09-07 | 33.206016837673 | wst-1-cell-proliferation-assay-kit | assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microtiter plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements cancers cell-based assay cell based assay cba | ||||
| 10010199 |
WST- |
- |
|
2007-09-11 | 60.442836095763 | wst-8-cell-proliferation-assay-kit | assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microwell plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements special:quarterly specialdiscount:50 specialstart:2007-12-01 specialend:2008-02-29 cell-based assay cell based assay cba | ||||
| 10010200 | XTT Cell Proliferation Assay Kit | - |
|
2007-09-11 | 41.906003683241 | xtt-cell-proliferation-assay-kit | assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microtiter plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements special:quarterly specialdiscount:50 specialstart:2007-12-01 specialend:2008-02-29 cell-based assay cell based assay cba | ||||
| 13661 |
YK- |
1037184-44-3 | ≥98% |
|
✓ | 2010-02-05 | 48.888888888889 | yk-4-279 | ES-FLI1 oncogene Ewing's sarcomas RNA helicases A RHAs tumors cancers inhibitors apoptosis inhibition inhibited Ewings YK 4-279 YK4279 YK 4279 YK 4 279 |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2010 Cayman Chemical Company
Quick Search